New Antibody Alert by Bio X Cell: anti-mouse CXCL16 (SR-PSOX)

by | Feb 10, 2025 | Cancer, Immunology, in vivo Studies

IN VIVO ANTIBODIES FROM BIO X CELL

New product from Bio X Cell: InVivoMAb anti-mouse CXCL16 (SR-PSOX)

We are proud to introduce a new product from Bio X Cell, anti-mouse CXCK16 (SR-PSOX) antibody. 

Anti-mouse CXCL16 (SR-PSOX) antibody targets the CXCL16 chemokine, which plays a crucial role in attracting CXCR6-expressing immune cells, such as activated T cells and NK cells. In cancer, CXCL16 can act as a tumor suppressor in some contexts while promoting invasiveness in others; its expression is associated with increased T-cell infiltration and improved prognosis in certain tumors.

By neutralizing CXCL16, this antibody serves as a valuable research tool for studying immune responses and tumor biology in mouse models. 

All products listed on this site and sold through LAB-A-PORTER Limited are for research use only (RUO). Not for human use. Not for therapeutic or diagnostic use.

ABOUT BIO X CELL

Antibodies For In Vivo Research

Bio X Cell antibodies are formulated for in vivo experiments and used extensively in animal models of human disease. They feature greater than 95% purity, ultra-low endotoxin levels, and are presevative, stabilizer, and carrier protein-free. Bio X Cell has developed a wide range of antibodies for immuno-oncology, immunology, and neuroscience research. Their products are cited in over 15,000 publications that detail a broad range of applications, including in vivo cell-specific depletion, cytokine neutralization, immune checkpoint blockade, and more.

 

    • Exceptional Purity
    • Pathogen Free
    • Ultra-low Endotoxin Level
    • Advanced Binding Validation
    • Low Protein Aggregation
    • Marching Isotype Control Antibodies

All products listed on this site and sold through LAB-A-PORTER Limited are for research use only (RUO). Not for human use. Not for therapeutic or diagnostic use.

LAB-A-PORTER IS THE EXCLUSIVE DISTRIBUTOR OF BIO X CELL IN HONG KONG.

Contact us
Share This